ImmunityBio, Inc. (NASDAQ: IBRX) is a commercial-stage biotechnology company developing cell and immunotherapy products that are designed to help strengthen each patientās natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.
The Regulatory Affairs Program Manager leads cross-functional regulatory projects from strategy through execution, ensuring that all products meet global regulatory requirements and are launched on schedule. This role partners closely with R&D, Clinical, Quality, Manufacturing, and Commercial teams to develop and implement regulatory strategies, manage submission timelines, and drive successful product approvals worldwide.
ImmunityBio, Inc. (NASDAQ: IBRX) is a commercial-stage biotechnology company developing cell and immunotherapy products that are designed to help strengthen each patientās natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells.
ImmunityBio, Inc.